|
Progressive Supranuclear Palsy (PSP) Summary Statistics – Farrell et al., 2024 (via DSS) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics- Hoglinger et al. (2011) |
|
|
|
|
Proteomic profiling identified plasma biomarkers for SARS-CoV-2 infection and severity of COVID-19 patients (via DSS) |
|
|
|
|
Resolving mutations in challenging genomic regions to test association with disease phenotypes (via DSS) |
|
|
|
|
Results of gene - based weighted burden analyses using SCOREASSOC and GENEVARASSOC and multivariate analyses of variants near APOE applied to the ADSP Discovery Case - Control Based Extension Study. |
|
|
|
|
Results of gene-based weighted burden analyses using SCOREASSOC and GENEVARASSOC applied to the ADSP discovery sample |
|
|
|
|
ROSMAP GWAS |
|
|
750173 |
|
ROSMAP2 GWAS |
|
|
658816 |
|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
|
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease – Eissman et al., 2022 (via DSS) |
|
|
|
|
Sex differences in the genetic predictors of Alzheimer’s pathology – Dumitrescu et al., 2019 (via DSS) |
|
|
|
|
Sex-specific genetic architecture of late-life memory performance (via DSS) |
|
|
|
|
Sex-specific genetic predictors of Alzheimer’s disease biomarkers – Deming et al., 2018 (via DSS) |
|
|
|
|
Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes- Wang et al. 2021 |
|
|
|
|
Singapore Longitudinal study of Vascular Cognitive Impairment and Dementia |
|
|
|
|
SORL1 coding variants and risk for AD |
|
|
89 |
|
SORL1 coding variants and risk for AD |
|
|
89 |
|
Summary Statistics of IGAP Age at onset survival GWAS dataset - Huang KL et al. (2017) |
|
|
|
|
TARCC GWAS |
|
|
648974 |
|
TGEN II GWAS |
|
|
759916 |
